{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:56:33Z","timestamp":1784775393689,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001648","name":"European Foundation for the Study of Diabetes","doi-asserted-by":"publisher","award":["EFSD\/Lilly Young investigator Research Award Programme 2022"],"award-info":[{"award-number":["EFSD\/Lilly Young investigator Research Award Programme 2022"]}],"id":[{"id":"10.13039\/501100001648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017726","name":"Fondazione Diabete Ricerca","doi-asserted-by":"publisher","award":["SID \u2013 Fondazione Diabete Ricerca 2022"],"award-info":[{"award-number":["SID \u2013 Fondazione Diabete Ricerca 2022"]}],"id":[{"id":"10.13039\/100017726","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03095-2","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:36:10Z","timestamp":1771929370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["SGLT2 inhibitors reduce the salt sensitivity of blood pressure in type 2 diabetes via enhanced postprandial natriuresis"],"prefix":"10.1186","volume":"25","author":[{"given":"Martina","family":"Chiriac\u00f2","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Tric\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Sacchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Nesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Cimbalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Santoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Baldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Scozzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Giannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Natali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"3095_CR1","doi-asserted-by":"publisher","unstructured":"Bailey MA, Dhaun N, Salt Sensitivity. Causes, Consequences, and Recent Advances. Hypertension [Internet]. Lippincott Williams and Wilkins; 2024 [cited 2025 Jan 11];81:476\u201389. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.123.17959\/SUPPL_FILE\/HYP_HYPE-2021-17959_SUPP1.DOCX","DOI":"10.1161\/HYPERTENSIONAHA.123.17959\/SUPPL_FILE\/HYP_HYPE-2021-17959_SUPP1.DOCX"},{"key":"3095_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1161\/01.HYP.0000091267.39066.72","volume":"42","author":"E Obarzanek","year":"2003","unstructured":"Obarzanek E, Proschan MA, Vollmer WM, Moore TJ, Sacks FM, Appel LJ, et al. Individual blood pressure responses to changes in salt intake: results from the DASH-Sodium trial. Hypertens [Internet] Hypertens. 2003;42:459\u201367. https:\/\/doi.org\/10.1161\/01.HYP.0000091267.39066.72. [cited 2024 Dec 25];.","journal-title":"Hypertens [Internet] Hypertens"},{"key":"3095_CR3","doi-asserted-by":"publisher","unstructured":"Weinberger MH, Fineberg NS, Fineberg SE, Weinberger M. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension [Internet]. Lippincott Williams and Wilkins; 2001 [cited 2025 Jun 24];37:429\u201332. https:\/\/doi.org\/10.1161\/01.HYP.37.2.429\/ASSET\/7D0E5E92-0BF6-4912-9C50-06CDEFE1AB68\/ASSETS\/GRAPHIC\/HY02T0138001.JPEG","DOI":"10.1161\/01.HYP.37.2.429\/ASSET\/7D0E5E92-0BF6-4912-9C50-06CDEFE1AB68\/ASSETS\/GRAPHIC\/HY02T0138001.JPEG"},{"key":"3095_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0B013E32835F29F4","author":"M Bursztyn","year":"2013","unstructured":"Bursztyn M, Ben-Dov IZ. Sex differences in salt-sensitivity risk approximated from ambulatory blood pressure monitoring and mortality. Volume 31. Lippincott Williams and Wilkins; 2013. pp. 900\u20135. [cited 2025 Jun 24];. https:\/\/doi.org\/10.1097\/HJH.0B013E32835F29F4. J Hypertens [Internet]."},{"key":"3095_CR5","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/EURHEARTJ\/EHAD192","volume":"44","author":"N Marx","year":"2023","unstructured":"Marx N, Federici M, Sch\u00fctt K, M\u00fcller-Wieland D, Ajjan RA, Antunes MJ, et al. 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J [Internet] Eur Heart J. 2023;44:4043\u2013140. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHAD192. [cited 2026 Jan 8];.","journal-title":"Eur Heart J [Internet] Eur Heart J"},{"key":"3095_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004886\/SUPPL_FILE\/004886R2","author":"SL Hummel","year":"2018","unstructured":"Hummel SL, Karmally W, Gillespie BW, Helmke S, Teruya S, Wells J et al. Home-Delivered Meals Postdischarge From Heart Failure Hospitalization. Circ Heart Fail [Internet]. NLM (Medline); 2018 [cited 2025 Apr 23];11:e004886. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.117.004886\/SUPPL_FILE\/004886R2."},{"key":"3095_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006389\/SUPPL_FILE\/CIRCHF_CIRCHF-2019-006389_SUPP1.PDF","author":"A Kalogeropoulos","year":"2020","unstructured":"Kalogeropoulos A, Papadimitriou L, Georgiopoulou VV, Dunbar SB, Skopicki H, Butler J. Low- Versus Moderate-Sodium Diet in Patients with Recent Hospitalization for Heart Failure: the PROHIBIT (Prevent Adverse Outcomes in Heart Failure by Limiting Sodium) Pilot Study. Volume 13. Lippincott Williams and Wilkins; 2020. p. E006389. [cited 2025 Apr 23];. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.119.006389\/SUPPL_FILE\/CIRCHF_CIRCHF-2019-006389_SUPP1.PDF. Circ Heart Fail [Internet]."},{"key":"3095_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0B013E32835E8227","author":"K Gilbert","year":"2013","unstructured":"Gilbert K, Nian H, Yu C, Luther JM, Brown NJ. Fenofibrate lowers blood pressure in salt-sensitive but not salt-resistant hypertension. Volume 31. Lippincott Williams and Wilkins; 2013. p. 820. [cited 2025 Apr 23];. https:\/\/doi.org\/10.1097\/HJH.0B013E32835E8227. J Hypertens [Internet]."},{"key":"3095_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/hr.2016.2","volume":"39","author":"Y Takeshige","year":"2016","unstructured":"Takeshige Y, Fujisawa Y, Rahman A, Kittikulsuth W, Nakano D, Mori H, et al. A sodium-glucose co-transporter 2 inhibitor empagliflozin prevents abnormality of circadian rhythm of blood pressure in salt-treated obese rats. Hypertens Res [Internet] Hypertens Res. 2016;39:415\u201322. https:\/\/doi.org\/10.1038\/hr.2016.2. [cited 2021 Oct 17];.","journal-title":"Hypertens Res [Internet] Hypertens Res"},{"key":"3095_CR10","doi-asserted-by":"publisher","unstructured":"Kim S, Jo CH, Kim GH. Effects of empagliflozin on nondiabetic salt-sensitive hypertension in uninephrectomized rats. Hypertension research [Internet]. Hypertens Res; 2019 [cited 2021 Oct 17];42:1905\u201315. https:\/\/doi.org\/10.1038\/s41440-019-0326-3","DOI":"10.1038\/s41440-019-0326-3"},{"key":"3095_CR11","doi-asserted-by":"publisher","unstructured":"Wan N, Fujisawa Y, Kobara H, Masaki T, Nakano D, Rahman A, et al. Effects of an SGLT2 inhibitor on the salt sensitivity of blood pressure and sympathetic nerve activity in a nondiabetic rat model of chronic kidney disease. Hypertension research [Internet]. Volume 43. Nature Publishing Group; 2020. pp. 492\u20139. [cited 2021 Oct 17];. https:\/\/doi.org\/10.1038\/s41440-020-0410-8.","DOI":"10.1038\/s41440-020-0410-8"},{"key":"3095_CR12","doi-asserted-by":"publisher","DOI":"10.1152\/AJPRENAL.00053.2022\/ASSET\/IMAGES\/LARGE\/AJPRENAL.00053.2022_F010.JPEG","author":"O Kravtsova","year":"2022","unstructured":"Kravtsova O, Bohovyk R, Levchenko V, Palygin O, Klemens CA, Rieg T et al. SGLT2 inhibition effect on salt-induced hypertension, RAAS, and Na\u00fe transport in Dahl SS rats. Am J Physiol Renal Physiol [Internet]. American Physiological Society; 2022 [cited 2025 Feb 26];322:F692\u2013707. https:\/\/doi.org\/10.1152\/AJPRENAL.00053.2022\/ASSET\/IMAGES\/LARGE\/AJPRENAL.00053.2022_F010.JPEG."},{"key":"3095_CR13","doi-asserted-by":"publisher","unstructured":"Shao SC, Chang KC, Lin SJ, Chien RN, Hung MJ, Chan YY, et al. Favorable pleiotropic effects of sodium glucose cotransporter 2 inhibitors: head-to-head comparisons with dipeptidyl peptidase-4 inhibitors in type 2 diabetes patients. Cardiovasc diabetol [Internet]. Volume 19. BioMed Central Ltd.; 2020. pp. 1\u201311. [cited 2022 Apr 3];. https:\/\/doi.org\/10.1186\/S12933-020-0990-2\/FIGURES\/3.","DOI":"10.1186\/S12933-020-0990-2\/FIGURES\/3"},{"key":"3095_CR14","doi-asserted-by":"publisher","unstructured":"Baker WL, Buckley LF, Kelly MS, Bucheit JD, Parod ED, Brown R, Sons Inc. Effects of sodium-glucose cotransporter 2 inhibitors on 24-hour ambulatory blood pressure: a systematic review and meta-analysis. J Am Heart Assoc [Internet]. John Wiley and ; 2017 [cited 2025 Aug 2];6. https:\/\/doi.org\/10.1161\/JAHA.117.005686\/ASSET\/85A0F14D-9AF6-46C3-AFDF-5C5331565AE8\/ASSETS\/IMAGES\/LARGE\/JAH32250-FIG-0009.JPG","DOI":"10.1161\/JAHA.117.005686\/ASSET\/85A0F14D-9AF6-46C3-AFDF-5C5331565AE8\/ASSETS\/IMAGES\/LARGE\/JAH32250-FIG-0009.JPG"},{"key":"3095_CR15","doi-asserted-by":"publisher","unstructured":"van Ruiten CC, Smits MM, Kok MD, Sern\u00e9 EH, van Raalte DH, Kramer MHH et al. Mechanisms underlying the blood pressure Lowering effects of dapagliflozin, exenatide, and their combination in people with type 2 diabetes: a secondary analysis of a randomized trial. Cardiovasc diabetol [Internet]. BioMed Central Ltd; 2022 [cited 2025 Aug 3];21:63. https:\/\/doi.org\/10.1186\/S12933-022-01492-X","DOI":"10.1186\/S12933-022-01492-X"},{"key":"3095_CR16","doi-asserted-by":"publisher","unstructured":"Chiriac\u00f2 M, Tric\u00f2 D, Solini A. Mechanisms of cardio-renal protection of sodium-glucose cotransporter-2 inhibitors. Curr Opin Pharmacol [Internet]. Curr Opin Pharmacol; 2022 [cited 2024 Jul 27];66. https:\/\/doi.org\/10.1016\/J.COPH.2022.102272","DOI":"10.1016\/J.COPH.2022.102272"},{"key":"3095_CR17","doi-asserted-by":"publisher","unstructured":"Yasui A, Lee G, Hirase T, Kaneko T, Kaspers S, von Eynatten M, et al. Empagliflozin induces transient diuresis without changing Long-Term overall fluid balance in Japanese patients with type 2 diabetes. Volume 9. Springer Healthcare; 2018. pp. 863\u201371. [cited 2024 Nov 27];. https:\/\/doi.org\/10.1007\/S13300-018-0385-5\/FIGURES\/2.","DOI":"10.1007\/S13300-018-0385-5\/FIGURES\/2"},{"key":"3095_CR18","doi-asserted-by":"publisher","first-page":"771","DOI":"10.2337\/dc16-2724","volume":"40","author":"E Ferrannini","year":"2017","unstructured":"Ferrannini E, Baldi S, Frascerra S, Astiarraga B, Barsotti E, Clerico A, et al. Renal handling of ketones in response to sodium-glucose cotransporter 2 Inhibition in patients with type 2 diabetes. Diabetes Care [Internet] Diabetes Care. 2017;40:771\u20136. https:\/\/doi.org\/10.2337\/dc16-2724. [cited 2021 Oct 17];.","journal-title":"Diabetes Care [Internet] Diabetes Care"},{"key":"3095_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-021-01385-5","volume":"20","author":"A Natali","year":"2021","unstructured":"Natali A, Nesti L, Tric\u00f2 D, Ferrannini E. Effects of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiac structure and function: a narrative review of clinical evidence. Cardiovasc Diabetol [Internet] BioMed Cent. 2021;20:1\u201316. https:\/\/doi.org\/10.1186\/s12933-021-01385-5. [cited 2021 Oct 16];.","journal-title":"Cardiovasc Diabetol [Internet] BioMed Cent"},{"key":"3095_CR20","doi-asserted-by":"publisher","first-page":"771","DOI":"10.2337\/dc16-2724","volume":"40","author":"E Ferrannini","year":"2017","unstructured":"Ferrannini E, Baldi S, Frascerra S, Astiarraga B, Barsotti E, Clerico A, et al. Renal handling of ketones in response to sodium-glucose cotransporter 2 Inhibition in patients with type 2 diabetes. Diabetes Care Diabetes Care. 2017;40:771\u20136. https:\/\/doi.org\/10.2337\/dc16-2724.","journal-title":"Diabetes Care Diabetes Care"},{"key":"3095_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.10.018","author":"PE Stevens","year":"2024","unstructured":"Stevens PE, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK et al. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int [Internet]. Elsevier B.V.; 2024 [cited 2026 Jan 9];105:S117\u2013314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018."},{"key":"3095_CR22","doi-asserted-by":"publisher","unstructured":"Elijovich F, Weinberger MH, Anderson CAM, Appel LJ, Bursztyn M, Cook NR, et al. Salt sensitivity of blood pressure: A scientific statement from the American heart Association. Hypertension [Internet]. Volume 68. Lippincott Williams and Wilkins; 2016. pp. e7\u201346. [cited 2021 Apr 25];. https:\/\/doi.org\/10.1161\/HYP.0000000000000047.","DOI":"10.1161\/HYP.0000000000000047"},{"key":"3095_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/AJCN\/61.2.269","volume":"61","author":"A Piccoli","year":"1995","unstructured":"Piccoli A, Nigrelli S, Caberlotto A, Bottazzo S, Rossi B, Pillon L, et al. Bivariate normal values of the bioelectrical impedance vector in adult and elderly populations. Am J Clin Nutr [Internet] Am J Clin Nutr. 1995;61:269\u201370. https:\/\/doi.org\/10.1093\/AJCN\/61.2.269. [cited 2025 Feb 1];.","journal-title":"Am J Clin Nutr [Internet] Am J Clin Nutr"},{"key":"3095_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/HJH.0b013e328316bb87","volume":"27","author":"J He","year":"2009","unstructured":"He J, Gu D, Chen J, Jaquish CE, Rao DC, Hixson JE, et al. Gender difference in blood pressure responses to dietary sodium intervention in the GenSalt study. J Hypertens [Internet] J Hypertens. 2009;27:48\u201354. https:\/\/doi.org\/10.1097\/HJH.0b013e328316bb87. [cited 2021 Oct 20];.","journal-title":"J Hypertens [Internet] J Hypertens"},{"key":"3095_CR25","doi-asserted-by":"publisher","unstructured":"Hallow KM, Helmlinger G, Greasley PJ, McMurray JJV, Boulton DW. Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis. Diabetes Obes Metab. John Wiley & Sons, Ltd; 2018. pp. 479\u201387. https:\/\/doi.org\/10.1111\/dom.13126","DOI":"10.1111\/dom.13126"},{"key":"3095_CR26","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1172\/JCI107996","volume":"55","author":"RA DeFronzo","year":"1975","unstructured":"DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest Am Soc Clin Invest. 1975;55:845\u201355. https:\/\/doi.org\/10.1172\/JCI107996.","journal-title":"J Clin Invest Am Soc Clin Invest"},{"key":"3095_CR27","doi-asserted-by":"publisher","unstructured":"DeFronzo RA. The effect of insulin on renal sodium metabolism - A review with clinical implications. Diabetologia [Internet]. Volume 21. Springer-; 1981. pp. 165\u201371. [cited 2025 Aug 6];. https:\/\/doi.org\/10.1007\/BF00252649\/METRICS.","DOI":"10.1007\/BF00252649\/METRICS"},{"key":"3095_CR28","doi-asserted-by":"publisher","unstructured":"Heyman SN, Bursztyn M, Szalat A, Muszkat M, Abassi Z, Fasting-Induced Natriuresis and SGLT:, Frontiers Media SA. 2020 [cited 2025 Aug 6];11:516858. https:\/\/doi.org\/10.3389\/FENDO.2020.00217\/BIBTEX","DOI":"10.3389\/FENDO.2020.00217\/BIBTEX"},{"key":"3095_CR29","doi-asserted-by":"publisher","unstructured":"Packer M, Wilcox CS, Testani JM. Critical analysis of the effects of SGLT2 inhibitors on renal tubular Sodium, water and chloride homeostasis and their role in influencing heart failure Outcomes. Circulation [Internet]. Volume 148. Lippincott Williams and Wilkins; 2023. pp. 354\u201372. [cited 2025 Apr 27];. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.064346.","DOI":"10.1161\/CIRCULATIONAHA.123.064346"},{"key":"3095_CR30","doi-asserted-by":"publisher","unstructured":"Marton A, Saffari SE, Rauh M, Sun RN, Nagel AM, Linz P et al. Water conservation overrides osmotic diuresis during SGLT2 Inhibition in patients with heart failure. J Am Coll Cardiol [Internet]. Elsevier; 2024 [cited 2025 Apr 27];83:1386\u201398. https:\/\/doi.org\/10.1016\/J.JACC.2024.02.020","DOI":"10.1016\/J.JACC.2024.02.020"},{"key":"3095_CR31","doi-asserted-by":"publisher","unstructured":"Burnier M, Brunner HR. Neurohormonal consequences of diuretics in different cardiovascular syndromes. Eur Heart J [Internet] Eur Heart J. 1992;28\u201333. https:\/\/doi.org\/10.1093\/EURHEARTJ\/13.SUPPL_G.28. [cited 2026 Jan 10];13 Suppl G.","DOI":"10.1093\/EURHEARTJ\/13.SUPPL_G.28"},{"key":"3095_CR32","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1159\/000082314","volume":"24","author":"GH Kim","year":"2004","unstructured":"Kim GH. Long-term adaptation of renal ion transporters to chronic diuretic treatment. Am J Nephrol [Internet] Am J Nephrol. 2004;24:595\u2013605. https:\/\/doi.org\/10.1159\/000082314. [cited 2026 Jan 10];.","journal-title":"Am J Nephrol [Internet] Am J Nephrol"},{"key":"3095_CR33","doi-asserted-by":"publisher","unstructured":"Collard D, Brouwer TF, Olde Engberink RHG, Zwinderman AH, Vogt L, Van Den Born BJH. Initial Estimated Glomerular Filtration Rate Decline and Long-Term Renal Function During Intensive Antihypertensive Therapy: a Post Hoc Analysis of the SPRINT and ACCORD-BP Randomized Controlled Trials. Hypertension [Internet]. Lippincott Williams and Wilkins; 2020 [cited 2025 Apr 27];75:1205\u201312. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.14659\/SUPPL_FILE\/HYP_HYPE202014659-T_SUPP2.PDF","DOI":"10.1161\/HYPERTENSIONAHA.119.14659\/SUPPL_FILE\/HYP_HYPE202014659-T_SUPP2.PDF"},{"key":"3095_CR34","doi-asserted-by":"publisher","unstructured":"Zelniker TA, Braunwald E, Elsevier USA. 2020 [cited 2026 Jan 10];75:435\u201347. https:\/\/doi.org\/10.1016\/J.JACC.2019.11.036;JOURNAL:JOURNAL:JAC;PAGE:STRING:ARTICLE\/CHAPTER.","DOI":"10.1016\/J.JACC.2019.11.036;JOURNAL:JOURNAL:JAC;PAGE:STRING:ARTICLE\/CHAPTER."},{"key":"3095_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/AJH\/HPAF130","author":"CA M\u00f8ller","year":"2025","unstructured":"M\u00f8ller CA, Nielsen SF, Mose FH. The Effect of SGLT2 Inhibitors on Blood Pressure in Relation to Baseline Kidney Function: a Volume XX. Oxford University Press (OUP); 2025. pp. 1\u201312. [cited 2026 Jan 9];. https:\/\/doi.org\/10.1093\/AJH\/HPAF130. Systematic Literature Review and Data Analysis. Am J Hypertens [Internet]."},{"key":"3095_CR36","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000173402","volume":"14","author":"JP Briggs","year":"1991","unstructured":"Briggs JP, Lorenz JN, Weihprecht H, Schnermann J. Macula densa control of Renin secretion. Ren Physiol Biochem [Internet] Ren Physiol Biochem. 1991;14:164\u201374. https:\/\/doi.org\/10.1159\/000173402. [cited 2025 Apr 17];.","journal-title":"Ren Physiol Biochem [Internet] Ren Physiol Biochem"},{"key":"3095_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2016.163","author":"J Hartupee","year":"2016","unstructured":"Hartupee J, Mann DL. Neurohormonal activation in heart failure with reduced ejection fraction. Nat Reviews Cardiol. 2016;14:30\u20138. https:\/\/doi.org\/10.1038\/nrcardio.2016.163. [cited 2025 Feb 24];. 2016 14:1 [Internet]. Nature Publishing Group."},{"key":"3095_CR38","doi-asserted-by":"publisher","unstructured":"Sagnella GA, Markandu ND, Buckley MG, Miller MA, Singer DRJ, MacGregor GA. Plasma atrial natriuretic Peptide, Aldosterone, and plasma Renin activity responses to gradual changes in dietary sodium intake. Volume 3. Oxford Academic; 1990. pp. 863\u20135. [cited 2025 Apr 17];. https:\/\/doi.org\/10.1093\/AJH\/3.11.863.","DOI":"10.1093\/AJH\/3.11.863"},{"key":"3095_CR39","doi-asserted-by":"publisher","first-page":"R813","DOI":"10.1152\/AJPREGU.00355.2019","volume":"318","author":"F Sayk","year":"2020","unstructured":"Sayk F, Twesten C, Adametz I, Franzen K, Vonthein R, Dodt C, et al. Angiotensin II-mediated nondipping during sleep in healthy humans: effects on baroreflex function at subsequent daytime. Am J Physiol Regul Integr Comp Physiol [Internet] Am J Physiol Regul Integr Comp Physiol. 2020;318:R813\u201321. https:\/\/doi.org\/10.1152\/AJPREGU.00355.2019. [cited 2025 Nov 21];.","journal-title":"Am J Physiol Regul Integr Comp Physiol [Internet] Am J Physiol Regul Integr Comp Physiol"},{"key":"3095_CR40","doi-asserted-by":"publisher","unstructured":"Patel SM, Kang YM, Im KA, Neuen BL, Anker SD, Bhatt DL et al. Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: a SMART-C Collaborative Meta-Analysis. Circulation [Internet]. Lippincott Williams and Wilkins; 2024 [cited 2024 Nov 26];149:1789\u2013801. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.069568\/SUPPL_FILE\/COTR149_23.PDF","DOI":"10.1161\/CIRCULATIONAHA.124.069568\/SUPPL_FILE\/COTR149_23.PDF"},{"key":"3095_CR41","doi-asserted-by":"publisher","unstructured":"Doukky R, Avery E, Mangla A, Collado FM, Ibrahim Z, Poulin MF et al. Impact of dietary sodium restriction on heart failure outcomes. JACC heart fail [Internet]. JACC Heart Fail; 2016 [cited 2021 Oct 16];4:24\u201335. https:\/\/doi.org\/10.1016\/j.jchf.2015.08.007","DOI":"10.1016\/j.jchf.2015.08.007"},{"key":"3095_CR42","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1001\/JAMAINTERNMED.2018.4673","volume":"178","author":"KR Mahtani","year":"2018","unstructured":"Mahtani KR, Heneghan C, Onakpoya I, Tierney S, Aronson JK, Roberts N, et al. Reduced salt intake for heart failure: a systematic review. JAMA Intern Med [Internet] JAMA. 2018;178:1693\u2013700. https:\/\/doi.org\/10.1001\/JAMAINTERNMED.2018.4673. [cited 2025 Feb 26];. Intern Med.","journal-title":"JAMA Intern Med [Internet] JAMA"},{"key":"3095_CR43","doi-asserted-by":"publisher","unstructured":"Mullens W, Damman K, Dhont S, Banerjee D, Bayes-Genis A, Cannata A et al. Dietary sodium and fluid intake in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC. Eur J Heart Fail [Internet]. John Wiley & Sons, Ltd; 2024 [cited 2024 Aug 18];26:730\u201341. https:\/\/doi.org\/10.1002\/EJHF.3244","DOI":"10.1002\/EJHF.3244"},{"key":"3095_CR44","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1093\/EURHEARTJ\/EHX035","volume":"38","author":"W Mullens","year":"2017","unstructured":"Mullens W, Verbrugge FH, Nijst P, Tang WHW. Renal sodium avidity in heart failure: from pathophysiology to treatment strategies. Eur Heart J [Internet] Eur Heart J. 2017;38:1872\u201382. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHX035. [cited 2025 Feb 26];.","journal-title":"Eur Heart J [Internet] Eur Heart J"},{"key":"3095_CR45","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1161\/HYPERTENSIONAHA.109.131235","volume":"54","author":"E Pimenta","year":"2009","unstructured":"Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell\u2019Italia LJ, et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertens [Internet] Hypertens. 2009;54:475\u201381. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.131235. [cited 2026 Jan 10];.","journal-title":"Hypertens [Internet] Hypertens"},{"key":"3095_CR46","doi-asserted-by":"publisher","DOI":"10.4065\/80.8.1029\/ASSET\/CD1E7C94-045D-46DA-88DA-63621291E4C3\/MAIN.ASSETS\/GR4.GIF","author":"PM McKie","year":"2005","unstructured":"McKie PM, Burnett JC. B-type natriuretic peptide as a biomarker beyond heart failure: Speculations and opportunities. Volume 80. Elsevier Ltd; 2005. pp. 1029\u201336. [cited 2025 Apr 27];. https:\/\/doi.org\/10.4065\/80.8.1029\/ASSET\/CD1E7C94-045D-46DA-88DA-63621291E4C3\/MAIN.ASSETS\/GR4.GIF. Mayo Clin Proc [Internet]."},{"key":"3095_CR47","doi-asserted-by":"publisher","unstructured":"Laffer CL, Scott RC, Titze JM, Luft FC, Elijovich F. Hemodynamics and Salt-and-Water Balance Link Sodium Storage and Vascular Dysfunction in Salt-Sensitive Subjects. Hypertension [Internet]. Lippincott Williams and Wilkins; 2016 [cited 2025 Apr 27];68:195\u2013203. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.116.07289\/ASSET\/40260CF0-CC02-4575-BF1C-0C70EC88D20B\/ASSETS\/GRAPHIC\/195FIG04.JPEG","DOI":"10.1161\/HYPERTENSIONAHA.116.07289\/ASSET\/40260CF0-CC02-4575-BF1C-0C70EC88D20B\/ASSETS\/GRAPHIC\/195FIG04.JPEG"},{"key":"3095_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2021.07.003","author":"P Bjornstad","year":"2021","unstructured":"Bjornstad P, Greasley PJ, Wheeler DC, Chertow GM, Langkilde AM, Heerspink HJL, et al. The Potential Roles of Osmotic and Nonosmotic Sodium Handling in Mediating the Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Heart Failure. Volume 27. Elsevier B.V.; 2021. pp. 1447\u201355. [cited 2025 Nov 21];. https:\/\/doi.org\/10.1016\/j.cardfail.2021.07.003. J Card Fail [Internet]."},{"key":"3095_CR49","doi-asserted-by":"publisher","unstructured":"Gupta DK, Lewis CE, Varady KA, Su YR, Madhur MS, Lackland DT et al. Effect of dietary sodium on blood pressure: a crossover Trial. JAMA [Internet]. American Medical Association; 2023 [cited 2026 Jan 8];330:2258\u201366. https:\/\/doi.org\/10.1001\/JAMA.2023.23651","DOI":"10.1001\/JAMA.2023.23651"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03095-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03095-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03095-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:52:10Z","timestamp":1774885930000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03095-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3095"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03095-2","relation":{"references":[{"id-type":"doi","id":"10.1097\/HJH.0B013E32835F29F4","asserted-by":"subject"},{"id-type":"doi","id":"10.1161\/CIRCHEARTFAILURE.117.004886\/SUPPL_FILE\/004886R2","asserted-by":"subject"},{"id-type":"doi","id":"10.1161\/CIRCHEARTFAILURE.119.006389\/SUPPL_FILE\/CIRCHF_CIRCHF-2019-006389_SUPP1.PDF","asserted-by":"subject"},{"id-type":"doi","id":"10.1097\/HJH.0B013E32835E8227","asserted-by":"subject"},{"id-type":"doi","id":"10.1152\/AJPRENAL.00053.2022\/ASSET\/IMAGES\/LARGE\/AJPRENAL.00053.2022_F010.JPEG","asserted-by":"subject"},{"id-type":"doi","id":"10.1016\/j.kint.2023.10.018","asserted-by":"subject"},{"id-type":"doi","id":"10.1093\/AJH\/HPAF130","asserted-by":"subject"},{"id-type":"doi","id":"10.1038\/nrcardio.2016.163","asserted-by":"subject"},{"id-type":"doi","id":"10.4065\/80.8.1029\/ASSET\/CD1E7C94-045D-46DA-88DA-63621291E4C3\/MAIN.ASSETS\/GR4.GIF","asserted-by":"subject"},{"id-type":"doi","id":"10.1016\/j.cardfail.2021.07.003","asserted-by":"subject"}]},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"22 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the local Ethics Committee (protocol number 22661) and all study procedures were conducted following the Declaration of Helsinki. The study has been registered on Clinicaltrial.gov (NCT06007157). All participants provided written informed consent before enrolment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"104"}}